510(k) Report

510(k) · Cleared

Cleared

Rheumatoid Factor (RF)

K024067510(k) TraditionalCleared Jan 15, 200336-day reviewClass II21 CFR 866.5775

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Abbott Laboratories · DHR System, Test, Rheumatoid Factor

Cleared on Jan 15, 2003 as substantially equivalent to K002609 (Roche Diagnostics Corp., 2000) after a 36-day review. Its family tree reaches back 1 generation to 2000.

Decided
Jan 15, 2003
Review
36 days
Class
Class II
Product code
DHR
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K002609 (2000). No later device cites it as a predicate yet.

  1. Root · 1 generation backK002609 Tina-Quant Rheumatoid Factors II Test SystemRoche Diagnostics Corp. · 2000 · Recalled
  2. This deviceK024067 Rheumatoid Factor (RF)Abbott Laboratories · 2003
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K002609Tina-Quant Rheumatoid Factors II Test SystemRoche Diagnostics Corp.20001
0 (this device)K024067Rheumatoid Factor (RF)Abbott Laboratories2003—
FIG. 1 — Lineage of K024067, 2000–2003Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DHR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K002609Tina-Quant Rheumatoid Factors II Test System
Summary page 2
…7 Substantial Equivalence: The Rheumatoid Factor assay is substantially equivalent to the Roche Diagnostics Corp. Tina-quant RF 11assay (K002609) on the Hitachi@717 Analyzer. Both assays yield similar Performance Characteristics. Similarities: Both assays are…
Roche Diagnostics Corp.20001

Also cleared against K002609: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.
  • 1 other device also cites its predicate K002609.

How does its category compare?

All DHR devices

DHR System, Test, Rheumatoid Factor: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DHR

1in 2020

2007: 12009: 12010: 12011: 12015: 12016: 12017: 12018: 12019: 12020: 1
2007high 1 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DHR

Too few DHR 510(k)s in any year since 2007 to give a median.

Recalls per year · DHR

1in 2019

2010: 12011: 32012: 22018: 22019: 1
2007high 3 (2011) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DHR

2in 2025

2010: 192011: 4002012: 912018: 12024: 32025: 2
2007high 400 (2011) · low 0 (2007)2025

MAUDE reports naming product code DHR, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—00
20091—00
20101—119
20111—3400
20120—291
20130—00
20140—00
20151—00
20161—00
20171—00
20181—21
20191—10
20201—00
20210—00
20220—00
20230—00
20240—03
20250—02
20260—0—

What is it indicated for?

The Rheumatoid Factor assay is used for the quantitation of rheumatoid factor in human serum. Measurement of rheumatoid factor may aid in the diagnosis of rheumatoid arthritis.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K024067: Rheumatoid Factor (RF).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K024067

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026